tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
GlaxoSmithKline (GB:GSK)
LSE:GSK
UK Market
GSK
GlaxoSmithKline
RESEARCH TOOLSreports

GlaxoSmithKline (GSK) Stock News & Sentiment

Compare
1,127 Followers
GSK Chair Sir Jonathan Symonds Buys Additional Shares in the Company
Premium
Company Announcements
GSK Chair Sir Jonathan Symonds Buys Additional Shares in the Company
12h ago
GSK Wins EU Approval for Nucala in High‑Risk COPD, Extending Respiratory Biologics Lead
Premium
Company Announcements
GSK Wins EU Approval for Nucala in High‑Risk COPD, Extending Respiratory Biologics Lead
15h ago
GSK Discloses Share Sales by Senior Executive and Associated Insider
Premium
Company Announcements
GSK Discloses Share Sales by Senior Executive and Associated Insider
1d ago
GSK: Solid Near‑Term Delivery, Enhanced Shareholder Returns, and Compelling 2031 Growth Upside Support Buy Rating
Premium
Ratings
GSK: Solid Near‑Term Delivery, Enhanced Shareholder Returns, and Compelling 2031 Growth Upside Support Buy Rating
2d ago
GSK
Balancing Pipeline Upside and HIV Patent Cliff Risks: Justifying a Hold Rating Despite FX Drag and Valuation Richness
Premium
Ratings
Balancing Pipeline Upside and HIV Patent Cliff Risks: Justifying a Hold Rating Despite FX Drag and Valuation Richness
2d ago
GSK
GSK Posts Strong 2025 Results, Raises Dividend and Reaffirms Growth Outlook
Premium
Company Announcements
GSK Posts Strong 2025 Results, Raises Dividend and Reaffirms Growth Outlook
3d ago
GSK Updates Market on Total Voting Rights and Share Capital
Premium
Company Announcements
GSK Updates Market on Total Voting Rights and Share Capital
4d ago
More GB:GSK News >

GSK News on the Web

Trump Trade: Argentina says U.S. to cut hundreds of tariffs
TipRanks News
Neutral
GSK announces European Commission approved Nucala
TipRanks News
Bullish
GSK Chair Sir Jonathan Symonds Buys Additional Shares in the Company
TipRanks News
Bullish
Kepler Capital Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
TipRanks News
Neutral
EU gives GSK's Nucala green light for use in uncontrolled COPD
ShareCast
Bullish
GSK Wins EU Approval for Nucala in High‑Risk COPD, Extending Respiratory Biologics Lead
TipRanks News
Bullish
White House to launch direct-to-consumer drug site Trump Rx. Here's what to know
CNBC
Neutral
TrumpRx website using technology from GoodRx, STAT says
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
GB:GSK
Sector Average
Media Buzz
This Week26 articles
Weekly Average13.5 articles
News Sentiment
This Week87%
Sector Average74%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:GSK’s Media Buzz Sentiment?
26 articles about GB:GSK were published this week. In an average week, 13.5 articles are published.
    What is GB:GSK’s weekly average amount of articles?
    In an average week, 13.5 articles about GB:GSK are published.
      What is GB:GSK’s News Sentiment?
      87% of articles about GB:GSK were positive this week, compared to its sector average of 74%.
        Healthcare Stocks that are Trending in the News
        MMSIMerit Medical Systems
        EHCEncompass Health
        ROIVRoivant Sciences
        TECHBio-Techne
        DVADaVita
        Showing the stocks with the most bullish news sentiment over the past week